Bausch Health Companies Inc. (NYSE:BHC) Shares Purchased by Franklin Resources Inc.

Franklin Resources Inc. boosted its position in Bausch Health Companies Inc. (NYSE:BHC) by 1.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 5,316,822 shares of the company’s stock after acquiring an additional 56,446 shares during the period. Franklin Resources Inc. owned about 1.47% of Bausch Health Companies worth $42,855,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. grew its position in shares of Bausch Health Companies by 3.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,269,478 shares of the company’s stock valued at $10,373,000 after purchasing an additional 42,539 shares during the period. Cerity Partners LLC grew its holdings in Bausch Health Companies by 14.4% in the 3rd quarter. Cerity Partners LLC now owns 79,290 shares of the company’s stock valued at $647,000 after buying an additional 9,978 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Bausch Health Companies by 26.5% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 76,807 shares of the company’s stock valued at $628,000 after acquiring an additional 16,101 shares during the last quarter. Verition Fund Management LLC purchased a new position in shares of Bausch Health Companies during the 3rd quarter worth about $808,000. Finally, Centiva Capital LP acquired a new stake in shares of Bausch Health Companies in the third quarter worth approximately $951,000. 78.65% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Royal Bank of Canada cut their price target on shares of Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating on the stock in a research note on Thursday, January 30th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $8.00 target price (down from $12.00) on shares of Bausch Health Companies in a research report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $7.42.

Bausch Health Companies Stock Down 5.9 %

Bausch Health Companies stock opened at $5.34 on Friday. The firm has a fifty day moving average of $6.91 and a 200-day moving average of $7.69. Bausch Health Companies Inc. has a 52-week low of $3.96 and a 52-week high of $10.48. The firm has a market capitalization of $1.96 billion, a P/E ratio of -44.45, a PEG ratio of 0.37 and a beta of 0.43.

Bausch Health Companies (NYSE:BHC) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $1.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.65 by ($0.44). The company had revenue of $2.56 billion during the quarter, compared to analyst estimates of $2.51 billion. Bausch Health Companies had a negative net margin of 0.48% and a negative return on equity of 577.82%. On average, research analysts expect that Bausch Health Companies Inc. will post 4.41 EPS for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.